Nicola Milne

675 total citations
9 papers, 255 citations indexed

About

Nicola Milne is a scholar working on Endocrinology, Diabetes and Metabolism, Pharmacology and Oncology. According to data from OpenAlex, Nicola Milne has authored 9 papers receiving a total of 255 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Endocrinology, Diabetes and Metabolism, 4 papers in Pharmacology and 2 papers in Oncology. Recurrent topics in Nicola Milne's work include Pharmacology and Obesity Treatment (4 papers), Diabetes Treatment and Management (4 papers) and Diabetes Management and Research (2 papers). Nicola Milne is often cited by papers focused on Pharmacology and Obesity Treatment (4 papers), Diabetes Treatment and Management (4 papers) and Diabetes Management and Research (2 papers). Nicola Milne collaborates with scholars based in United Kingdom, Italy and India. Nicola Milne's co-authors include Marc Evans, John Wilding, Adie Viljoen, Debbie Hicks, Dipesh Patel, Geoff Riddington, Philip Newland‐Jones, Steve Baín, Naresh Kanumilli and Hood Thabit and has published in prestigious journals such as Diabetes Research and Clinical Practice, BMJ Quality & Safety and Journal of Cranio-Maxillofacial Surgery.

In The Last Decade

Nicola Milne

9 papers receiving 249 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Nicola Milne United Kingdom	7	138	53	48	33	32	9	255
Lisbeth M. Baggesen Denmark	11	191 1.4×	88 1.7×	106 2.2×	10 0.3×	67 2.1×	13	450
Danish Iltaf Satti United States	11	91 0.7×	28 0.5×	48 1.0×	32 1.0×	40 1.3×	42	354
Imperia Brajkovich Venezuela	9	212 1.5×	27 0.5×	34 0.7×	14 0.4×	41 1.3×	18	394
Elisa Nada Italy	9	342 2.5×	87 1.6×	106 2.2×	10 0.3×	75 2.3×	23	436
Sarah Cipriani Italy	8	136 1.0×	35 0.7×	29 0.6×	7 0.2×	18 0.6×	14	333
Areti Papadopoulou United Kingdom	5	40 0.3×	40 0.8×	24 0.5×	8 0.2×	26 0.8×	7	241
Stephen Glazer Canada	9	30 0.2×	24 0.5×	107 2.2×	13 0.4×	21 0.7×	11	450
Stefan Sultana United Kingdom	11	57 0.4×	25 0.5×	88 1.8×	12 0.4×	18 0.6×	19	291
Mads Faurby Denmark	8	164 1.2×	73 1.4×	48 1.0×	3 0.1×	30 0.9×	31	282
Simona Di Francesco Italy	10	39 0.3×	24 0.5×	17 0.4×	11 0.3×	12 0.4×	16	176

Countries citing papers authored by Nicola Milne

Since Specialization

Citations

This map shows the geographic impact of Nicola Milne's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nicola Milne with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nicola Milne more than expected).

Fields of papers citing papers by Nicola Milne

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nicola Milne. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nicola Milne. The network helps show where Nicola Milne may publish in the future.

Co-authorship network of co-authors of Nicola Milne

This figure shows the co-authorship network connecting the top 25 collaborators of Nicola Milne. A scholar is included among the top collaborators of Nicola Milne based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nicola Milne. Nicola Milne is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

Rutter, Martin K., Matthew Carr, Alison K. Wright, et al.. (2024). Indirect effects of the COVID-19 pandemic on diagnosing, monitoring, and prescribing in people with diabetes and strategies for diabetes service recovery internationally. Diabetes Research and Clinical Practice. 212. 111693–111693. 1 indexed citations

Seidu, Samuel, Sarah Davies, Philip Newland‐Jones, et al.. (2024). SGLT2 Inhibitors – The New Standard of Care for Cardiovascular, Renal and Metabolic Protection in Type 2 Diabetes: A Narrative Review. Diabetes Therapy. 15(5). 1099–1124. 17 indexed citations

Appleton, Richard, Richard Chin, Ailsa McLellan, et al.. (2022). Review of the new APLS guideline (2022): Management of the convulsing child. Archives of Disease in Childhood Education & Practice. 108(1). 43–48. 6 indexed citations

Carr, Matthew, Alison K. Wright, Lalantha Leelarathna, et al.. (2021). Impact of COVID-19 restrictions on diabetes health checks and prescribing for people with type 2 diabetes: a UK-wide cohort study involving 618 161 people in primary care. BMJ Quality & Safety. 31(7). 503–514. 59 indexed citations

Wheeler, David C., Dipesh Patel, Adie Viljoen, et al.. (2020). SGLT2 Inhibitors: Slowing of Chronic Kidney Disease Progression in Type 2 Diabetes. Diabetes Therapy. 11(12). 2757–2774. 27 indexed citations

Baín, Steve, Debbie Hicks, Dipesh Patel, et al.. (2019). SGLT2 Inhibitors: Cardiovascular Benefits Beyond HbA1c—Translating Evidence into Practice. Diabetes Therapy. 10(5). 1595–1622. 37 indexed citations

Wilding, John, Nicola Milne, Marc Evans, et al.. (2018). SGLT2 Inhibitors in Type 2 Diabetes Management: Key Evidence and Implications for Clinical Practice. Diabetes Therapy. 9(5). 1757–1773. 68 indexed citations

Abu-Serriah, M., Ashraf Ayoub, D. Walter Wray, et al.. (2006). Contour and volume assessment of repairing mandibular osteoperiosteal continuity defects in sheep using recombinant human osteogenic protein 1. Journal of Cranio-Maxillofacial Surgery. 34(3). 162–167. 8 indexed citations

Riddington, Geoff, et al.. (2000). Modelling choice and switching behaviour between Scottish ski centres. Applied Economics. 32(8). 1011–1018. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact